Compara mètodes

	Puntuació CHA₂DS₂-VASc	Puntuació APACHE II	Puntuació qSOFA
Camp	Avaluació clínica	Avaluació clínica	Avaluació clínica
Família	Process / pipeline	Process / pipeline	Process / pipeline
Any d'origen	2010	1985	2016
Autor original	Gregory Y. H. Lip, Robby Nieuwlaat, et al.	William A. Knaus, et al.	Sepsis-3 Taskforce
Tipus	Atrial fibrillation stroke risk stratification	ICU severity and mortality prediction	Rapid sepsis screening
Font seminal	Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272.	Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985). APACHE II: a severity of disease classification system. Critical Care Medicine, 13(10), 818-829.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Àlies	CHA2DS2VASc, Atrial fibrillation stroke risk	APACHE-II, APACHE2	Quick SOFA, qSOFA
Relacionats	3	3	3
Resum	The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.	The Acute Physiology and Chronic Health Evaluation (APACHE) II score, introduced by Knaus et al. in 1985, is a 71-point severity of illness classification system for critically ill patients. It combines acute physiological parameters, age, and chronic health status to predict intensive care unit (ICU) mortality, facilitating patient risk stratification and research standardization.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.